Trending at Lumira Ventures

Endotronix

jacki jenuth Current

Endotronix, a digital health medtech company, is developing an integrated platform to provide comprehensive, reimbursable health management tools for patients suffering from advanced heart failure.

enGene

jacki jenuth Current

enGene has a novel proprietary method to deliver therapeutic proteins to the gastrointestinal (GI) tract to treat diseases of the GI tract.

Exact Imaging

jacki jenuth Current

Exact Imaging is the world’s leader in high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies for prostate cancer.

Fusion Pharmaceuticals

jacki jenuth Current

Fusion Pharmaceuticals is a clinical-stage bio-pharmaceutical company developing next-generation radio-pharmaceuticals as precision medicines for the treatment of cancer.

G1 Therapeutics

jacki jenuth Current

G1 Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of novel small-molecule therapies to address significant unmet needs in oncology.

GenEp

Alyssia Watkin Current

GenEp is a biotechnology company developing therapies that address unmet needs in patients with epilepsy.

HistoSonics

Jennifer Schram Current

HistoSonics is a private medical device company whose mission is to redefine cancer treatment with a non-invasive, highly precise, cost-effective method of tumor destruction call Robotically Assisted Sonic Therapy (RAST™), based on the science of histotripsy.

Iterion Therapeutics

admin Current

Iterion Therapeutics is developing novel cancer therapeutics targeting nuclear β-catenin, a historically “undruggable” oncology target implicated in cell proliferation.

KalGene Inc

jacki jenuth Current

KalGene Inc is a pre-clinical stage company focussed on the development of precision medicine therapeutics to slow the progression of Alzheimer’s disease.

KisoJi Biotechnology

jacki jenuth Current

KisoJi Biotechnology is an early stage biotechnology company engaged in the development of antibodies for the treatment of various cancers.

Medexus Pharmaceuticals

Jennifer Schram Current

Medexus Pharmaceuticals is a leading specialty pharmaceutical company with a strong North American commercial platform. Medexus is focused on the therapeutic areas of auto-immune disease and pediatrics.

Notch Therapeutics

Jennifer Schram Current

Notch is an immune cell therapy company developing a next-generation pipeline of off-the-shelf, universally compatible, genetically tailored T cell therapeutics derived from renewable stem cell sources for the treatment of high-impact diseases, with an initial focus on cancer.

PIC Therapeutics

Alyssia Watkin Current

PIC Therapeutics is developing a new generation of therapeutics based on the modulation of RNA translation to improve how we treat cancer.

Specific Biologics

Alyssia Watkin Current

Specific Biologics is an early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through precision gene editing

Thryv Therapeutics

Alyssia Watkin Current

Thryv Therapeutics is developing therapies for genetic heart diseases pioneering a precision medicine approach to treat patients with Long QT Syndrome and potentially other arrhythmias.